Toggle navigation
About Us
Portfolio
News
Contact Us
Lightchain Capital
Recent News
November 09, 2023
Noninvasive Multitarget Stool RNA Test Proves Sensitive for Colorectal Cancer, Advanced Adenomas
READ MORE
November 09, 2023
Don Hardison Appointed Chairman of the Board at Geneoscopy
READ MORE
November 02, 2023
Wugen to Present New Clinical Data for WU-CART-007 and Preclinical Data for WU-NK-101, Two Investigational Allogeneic Cell Therapies for Challenging Hematologic Cancers, at American Society of Hematology Annual Meeting & Exposition
READ MORE
October 23, 2023
JAMA Publishes Geneoscopy’s Pivotal CRC-PREVENT Trial Results, Reporting Highest Sensitivity for Detecting Colorectal Cancer and Advanced Adenomas Among Available Noninvasive Screening Tests
READ MORE
October 05, 2023
Geneoscopy to Present and Exhibit at American College of Gastroenterology 2023 Annual Meeting
READ MORE
October 04, 2023
AI Proteins Announces the Appointment of Dr. Robert Stein to its Scientific Advisory Board
READ MORE
September 26, 2023
CareVet Partners with Blendvet™ & Hill’s Pet Nutrition to Launch Groundbreaking DEIB Initiative
READ MORE
September 26, 2023
NextRNA Therapeutics Strengthens Board of Directors with Appointment of Lori Friedman, PhD
READ MORE
September 09, 2023
Wugen Presents Initial Data from First-in-Human Phase 1/2 Trial of WU-CART-007 at the European Hematology Association (EHA) 2023 Congress
READ MORE
September 06, 2023
Geneoscopy CEO Andrew Barnell to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
READ MORE
1
2
3
4
...
14
Contact Us
Lightchain Capital, LLC
PO Box 31729
St. Louis, MO 63131
Submit
4837,4748,4815,4823,4811,4819,4822,4748,4772,4748,4789,4811,4830,4819,4815,4760,4792,4760,4791,4825,4828,4817,4811,4824,4778,4825,4831,4830,4822,4825,4825,4821,4760,4813,4825,4823,4748,4758,4748,4829,4831,4812,4820,4815,4813,4830,4748,4772,4748,4781,4825,4824,4830,4811,4813,4830,4746,4784,4825,4828,4823,4748,4839
©2021 LIGHTCHAIN CAPITAL, LLC All Rights Reserved |
Privacy Policy
Website by
Tidal Media Group